Why is Neuland Labs. falling/rising?

As of 29-Jul, Neuland Laboratories Ltd is experiencing a slight increase in its stock price, currently at 13,854.15, reflecting a change of 30.15 or 0.22% upward. Despite this positive movement today, the stock has underperformed its sector by 1.29%. Over the past week, it has shown a minimal gain of 0.03%, while over the last month, it has significantly outperformed the benchmark with a return of 14.45% compared to the Sensex's decline of 3.24%. However, the stock has seen a decrease in investor participation, with delivery volume falling by 7.26% against the 5-day average. The company maintains a strong ability to service debt, evidenced by a low Debt to EBITDA ratio of 0.57 times, and it has high institutional holdings at 33.66%, which may provide some stability.
In the broader market context, Neuland Laboratories Ltd's recent performance contrasts with the Sensex, which has decreased by 1.03% over the past week. While the stock has generated impressive returns over the past year at 64.80%, it has faced challenges, including a significant fall in net sales of 17.5% and negative results for the last three consecutive quarters. The company's valuation appears expensive with a Price to Book Value of 11.6, especially given the decline in profits by 33.3% over the same period. These mixed signals suggest that while the stock is currently rising, underlying financial difficulties may pose risks to its future performance.